Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

725 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Enrolling by invitation

TAF vs TDF During the Pregancy

NCT07542951

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • Department of Infectious Diseases, Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
View Trial Details
Active, not recruiting

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

NCT06963710

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Infection, +15 more
Locations
  • Aligos Investigational Site Coronado, California, United States
  • Aligos Investigational Site Pasadena, California, United States
  • Aligos Investigational Site Rialto, California, United States
  • Aligos Investigational Site San Francisco, California, United States
View all 41 locations
View Trial Details
Active, not recruiting

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Care CT Group Dasmariñas, Cavite, Philippines
View Trial Details
Active, not recruiting

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

NCT06497504

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 51 locations
View Trial Details
Active, not recruiting

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
  • GSK Investigational Site New York, United States
View all 80 locations
View Trial Details
Active, not recruiting

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 163 locations
View Trial Details

Related conditions